500
Participants
Start Date
July 1, 2023
Primary Completion Date
January 1, 2025
Study Completion Date
January 31, 2025
Intermittenly scanned continuous glucose monitoring
"Use of Intermittenly scanned continuous glucose monitoring (FreeStyle Libre) and meeting the glycometric data criteria:~* Time in range 70-180 mg/L \>70%~* Glycemic management index \<7%~* Coefficient of variation \<36%"
MODY genetic diagnostic test
"Those patients fulfilling the glycometric data criteria and with clinical MODY suspicion:~* diagnosis before 35 years of age~* first-degree family history of diabetes.~* negative pancreatic autoimmunity (Ac GAD, IA-2A and Ac ZnT8)~* preserved pancreatic beta cell function defined as C-peptide \> 0.2 ng/mL in the presence of plasma glycemia \>140 mg/dL).~Those patients who meet the previous criteria will proceed to the MODY genetic diagnostic test."
Valdepeñas General Hospital, Valdepeñas
Santa Barbara Hospital, Puertollano
La Mancha-Centro Hospital, Alcázar de San Juan
Virgen de la Luz University Hospital, Cuenca
Guadalajara University Hospital, Guadalajara
Maria Jose Picon, Málaga
Toledo University Hospital, Toledo
Virgen del Prado Hospital, Talavera de la Reina
Albacete University Hospital, Albacete
Castilla-La Mancha Health Service
OTHER